Your browser doesn't support javascript.
loading
The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire.
Petersen, Morten Aa; Aaronson, Neil K; Arraras, Juan I; Chie, Wei-Chu; Conroy, Thierry; Costantini, Anna; Dirven, Linda; Fayers, Peter; Gamper, Eva-Maria; Giesinger, Johannes M; Habets, Esther J J; Hammerlid, Eva; Helbostad, Jorunn; Hjermstad, Marianne J; Holzner, Bernhard; Johnson, Colin; Kemmler, Georg; King, Madeleine T; Kaasa, Stein; Loge, Jon H; Reijneveld, Jaap C; Singer, Susanne; Taphoorn, Martin J B; Thamsborg, Lise H; Tomaszewski, Krzysztof A; Velikova, Galina; Verdonck-de Leeuw, Irma M; Young, Teresa; Groenvold, Mogens.
Afiliação
  • Petersen MA; The Research Unit, Department of Palliative Medicine, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark. Electronic address: Morten.Aagaard.Petersen@regionh.dk.
  • Aaronson NK; Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Arraras JI; Medical Oncology Department, Hospital of Navarre, Pamplona, Spain.
  • Chie WC; Institute of Epidemiology and Preventive Medicine, Department of Public Health, College of Public Health, National Taiwan University, Taipei, Taiwan.
  • Conroy T; Medical Oncology Department, Institut de cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France.
  • Costantini A; Psychoncology Unit, Sant'Andrea Hospital, Faculty of Medicine, Psychology Sapienza University, Rome, Italy.
  • Dirven L; Department of Neurology, Haaglanden Medical Center, PO Box 432, 2501 CK The Hague, The Netherlands; Department of Neurology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands.
  • Fayers P; Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
  • Gamper EM; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Innsbruck Medical University, Innsbruck, Austria.
  • Giesinger JM; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Innsbruck Medical University, Innsbruck, Austria.
  • Habets EJJ; Department of Neurology, Haaglanden Medical Center, PO Box 432, 2501 CK The Hague, The Netherlands.
  • Hammerlid E; Department of Otolaryngology Head and Neck Surgery, Sahlgrenska University Hospital, Göteborg University, Göteborg, Sweden.
  • Helbostad J; Department of Neuroscience, Norwegian University of Science and Technology, St. Olav University Hospital, Trondheim, Norway.
  • Hjermstad MJ; European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Holzner B; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Innsbruck Medical University, Innsbruck, Austria.
  • Johnson C; Surgical Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Kemmler G; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Innsbruck Medical University, Innsbruck, Austria.
  • King MT; School of Psychology and Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
  • Kaasa S; Oslo University Hospital, University of Oslo, Norway and European Palliative Care Research Centre (PRC), Norwegian University of Science and Technology, Oslo, Norway.
  • Loge JH; Palliative Medicine Unit, University Hospital of Trondheim, Trondheim, Norway.
  • Reijneveld JC; Department of Neurology, Brain Tumor Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands; Department of Neurology, Brain Tumor Center Amsterdam, Academic Medical Center, Amsterdam, The Netherlands.
  • Singer S; Division of Epidemiology and Health Services Research, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre, Mainz, Germany.
  • Taphoorn MJB; Department of Neurology, Haaglanden Medical Center, PO Box 432, 2501 CK The Hague, The Netherlands; Department of Neurology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands.
  • Thamsborg LH; The Research Unit, Department of Palliative Medicine, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Tomaszewski KA; Health Outcomes Research Unit, Department of Gerontology, Geriatrics, and Social Work, Faculty of Education, Ignatianum Academy, Krakow, Poland.
  • Velikova G; Leeds Institute of Cancer and Pathology, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
  • Verdonck-de Leeuw IM; Department of Otolaryngology - Head & Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands.
  • Young T; East & North Hertfordshire NHS Trust Incorporating Mount Vernon Cancer Centre, Northwood, Middlesex, UK.
  • Groenvold M; The Research Unit, Department of Palliative Medicine, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark; Institute of Public Health, University of Copenhagen, Copenhagen, Denmark.
Eur J Cancer ; 100: 8-16, 2018 09.
Article em En | MEDLINE | ID: mdl-29936066
BACKGROUND: To optimise measurement precision, relevance to patients and flexibility, patient-reported outcome measures (PROMs) should ideally be adapted to the individual patient/study while retaining direct comparability of scores across patients/studies. This is achievable using item banks and computerised adaptive tests (CATs). The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) is one of the most widely used PROMs in cancer research and clinical practice. Here we provide an overview of the research program to develop CAT versions of the QLQ-C30's 14 functional and symptom domains. METHODS: The EORTC Quality of Life Group's strategy for developing CAT item banks consists of: literature search to identify potential candidate items; formulation of new items compatible with the QLQ-C30 item style; expert evaluations and patient interviews; field-testing and psychometric analyses, including factor analysis, item response theory calibration and simulation of measurement properties. In addition, software for setting up, running and scoring CAT has been developed. RESULTS: Across eight rounds of data collections, 9782 patients were recruited from 12 countries for the field-testing. The four phases of development resulted in a total of 260 unique items across the 14 domains. Each item bank consists of 7-34 items. Psychometric evaluations indicated higher measurement precision and increased statistical power of the CAT measures compared to the QLQ-C30 scales. Using CAT, sample size requirements may be reduced by approximately 20-35% on average without loss of power. CONCLUSIONS: The EORTC CAT Core represents a more precise, powerful and flexible measurement system than the QLQ-C30. It is currently being validated in a large independent, international sample of cancer patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Design de Software / Indicadores Básicos de Saúde / Medidas de Resultados Relatados pelo Paciente / Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspecto: Determinantes_sociais_saude / Patient_preference Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia / Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Design de Software / Indicadores Básicos de Saúde / Medidas de Resultados Relatados pelo Paciente / Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspecto: Determinantes_sociais_saude / Patient_preference Limite: Female / Humans / Male / Middle aged País/Região como assunto: Asia / Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2018 Tipo de documento: Article